Alpha2-macroglobulin gene polymorphisms show racial diversity and are not associated with Alzheimer's disease

Neuroreport. 2000 Apr 27;11(6):1167-71. doi: 10.1097/00001756-200004270-00005.

Abstract

Two genetic markers of the plasma protein alpha2-macroglobulin, a 5 bp deletion/insertion at the 5' splice site of exon 18 (A2MI) and the GTC/ATC (VaIIO00IIe) in exon 24 (A2M2), may have roles in the development of Alzheimer's disease (AD). Genotyping and linkage analysis of these markers in 426 Japanese sporadic AD patients, 85 autopsy-confirmed Caucasian AD cases, and, as controls, 382 Japanese and 65 Caucasians who were cognitively normal and 140 Japanese Parkinson's disease patients showed racial diversity in the frequencies and relationship of the two markers. Comparison of genotype and allele frequencies, stratification of the samples by the presence of the apolipoprotein E epsilon4 allele, and logistic regression analysis revealed no association of these markers with AD in either racial group.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4
  • Apolipoproteins E / genetics
  • Asian People / genetics*
  • Exons / genetics
  • Female
  • Gene Frequency / genetics
  • Genetic Linkage
  • Genetic Markers
  • Genotype
  • Humans
  • Logistic Models
  • Male
  • Parkinson Disease / genetics
  • Polymorphism, Genetic*
  • Risk Assessment
  • White People / genetics*
  • alpha-Macroglobulins / genetics*

Substances

  • Apolipoprotein E4
  • Apolipoproteins E
  • Genetic Markers
  • alpha-Macroglobulins